rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sarabjit Kour Nangra

Rediff.com  »  News  »   Sarabjit Kour Nangra

  News for Sarabjit Kour Nangra

  • Business

Ranbaxy suspends shipments from 2 plants; shares down over 2%

Shares of Ranbaxy Ltd on Tuesday fell over 2 per cent on the bourses after the company said it has suspended shipments of all pharmaceutical ingredients from its Tonsa and Dewas plants. "This......

Ranbaxy stock nosedives 20% on USFDA restrictions

Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market......

Suspected human hair in tablet cited in Ranbaxy ban

During a visit to a facility of leading drugmaker Ranbaxy Laboratories Ltd last year, US inspectors found that a black fibre embedded in a tablet may have been a hair from an employee's arm,......

Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Shares of Sun Pharmaceuticals on Thursday  fell sharply by nearly 7 per cent in early trade, after the pharmaceutical major and Israel's Teva agreed to pay a sum of $2.15 billion to Pfizer......

Indian firms eye $2.5-bn US drug market

Indian pharmaceutical majors are set to tap the generic anti-depressant market in the US, the largest pharma market in the world. The anti-depressant drug market in the US is primarily ruled by......
  Web results for Sarabjit Kour Nangra
Infosys shares up over 4% post earnings

Shares of IT major Infosys today gained over 4 per cent in morning trade after the company reported a healthy 21.6 per cent increase in... ...

http://www.business-standard.com/article/pti-stories/infosys-shares-up-over-4-post-earnings-114071100420_1.html
Brokerages see upside in Infy shares with new CEO on board

Brokerages give a thumbs up to the appointment of a new CEO at Infosys. The ending of the uncertainty about who will lead IT company... ...

http://businesstoday.intoday.in/story/infosys-new-ceo-vishal-sikka-to-boost-stocks/1/207671.html
Angel Broking

Cipla has signed a definitive agreement to acquire a 51% stake in a pharmaceuticals manufacturing and distribution business in Yemen (owned by a... ...

http://www.myiris.com/newsCentre/storyShow.php?fileR=20140630145705715&dir=2014/06/30&secID=corporates&code1=&code=
Ranbaxy gets FDA nod to sell Novartis's Diovan generic

— By , June 28, 2014 12:11 am New Delhi : Ohm Laboratories Inc, the wholly-owned US subsidiary of Ranbaxy Laboratories Ltd, has received approval... ...

http://freepressjournal.in/ranbaxy-gets-fda-nod-to-sell-novartiss-diovan-generic/
Angel

Sarabjit Kour Nangra VP Research- Pharma Angel Broking W The Nexium Generic is a bigger opportunity for Ranbaxy than Valcyte generic, she... ...

http://www.moneycontrol.com/news/business/nexium-generic-next-big-opportunity-for-ranbaxy-angel_1113652.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z